Regeneron Pharmaceuticals, Inc. (REGN)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
| Previous close | 634.00 |
| Open | 637.77 |
| Bid | 620.89 x 800 |
| Ask | 636.80 x 1100 |
| Day's range | 623.12 - 641.79 |
| 52-week range | 441.00 - 686.62 |
| Volume | |
| Avg. volume | 764,020 |
| Market cap | 68.307B |
| Beta (5Y monthly) | 0.19 |
| PE ratio (TTM) | 10.16 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Glaxo (GSK), Vir COVID Drug Appears Effective Against Omicron
Glaxo (GSK) and Vir Biotechnology announce promising pre-clinical data from the study of their antibody candidate, sotrovimab, against mutations found in the Omicron variant.
- Zacks
COVID-19 Vaccine & Drug Makers Gear Up to Fight Omicron
The Omicron variant ignites fears that currently available COVID-19 vaccines and treatments could be less effective against it. MRNA, PFE, BNTX, REGN and JNJ are some of the industry players gearing up to fight against this new variant.
- Yahoo Finance Video
'Investors need to take a longer term perspective' amid market volatility, strategist says
Hennion & Walsh CIO Kevin Mahn joins Yahoo Finance Live to discuss the stock market amid heightened market volatility in recent days.
© 2021 Yahoo. All rights reserved.
